Prelude Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,154
| Closed | -$446K | – | 1411 |
|
|
2025
Q4 | $446K | Sell |
2,154
-2,517
| -54% | -$498K | 0.03% | 589 |
|
|
2025
Q3 | $866K | Sell |
4,671
-519
| -10% | -$88.9K | 0.07% | 340 |
|
|
2025
Q2 | $793K | Buy |
5,190
+1,262
| +32% | +$194K | 0.08% | 309 |
|
|
2025
Q1 | $651K | Buy |
3,928
+786
| +25% | +$123K | 0.05% | 429 |
|
|
2024
Q4 | $454K | Sell |
3,142
-18,956
| -86% | -$2.94M | 0.03% | 628 |
|
|
2024
Q3 | $3.58M | Buy |
22,098
+18,708
| +552% | +$2.98M | 0.22% | 108 |
|
|
2024
Q2 | $495K | Sell |
3,390
-7,259
| -68% | -$1.08M | 0.03% | 550 |
|
|
2024
Q1 | $1.68M | Buy |
+10,649
| New | +$1.7M | 0.09% | 275 |
|
|
2022
Q2 | – | Sell |
-4,669
| Closed | -$827K | – | 1936 |
|
|
2022
Q1 | $827K | Buy |
4,669
+163
| +4% | +$27.7K | 0.02% | 660 |
|
|
2021
Q4 | $771K | Sell |
4,506
-5,601
| -55% | -$917K | 0.02% | 751 |
|
|
2021
Q3 | $1.63M | Sell |
10,107
-10,450
| -51% | -$1.78M | 0.04% | 378 |
|
|
2021
Q2 | $3.39M | Buy |
20,557
+3,677
| +22% | +$609K | 0.1% | 146 |
|
|
2021
Q1 | $2.77M | Buy |
16,880
+10,886
| +182% | +$1.76M | 0.07% | 233 |
|
|
2020
Q4 | $943K | Buy |
5,994
+2,403
| +67% | +$355K | 0.02% | 490 |
|
|
2020
Q3 | $535K | Sell |
3,591
-3,675
| -51% | -$544K | 0.03% | 428 |
|
|
2020
Q2 | $1.02M | Buy |
+7,266
| New | +$1.06M | 0.06% | 316 |
|
|
2019
Q4 | – | Sell |
-5,035
| Closed | -$683K | – | 2083 |
|
|
2019
Q3 | $651K | Buy |
+5,035
| New | +$663K | 0.03% | 453 |
|
|
2017
Q3 | – | Sell |
-469
| Closed | -$62K | – | 1766 |
|
|
2017
Q2 | $62K | Buy |
+469
| New | +$59.8K | 0.01% | 933 |
|
|
2017
Q1 | – | Sell |
-4,201
| Closed | -$484K | – | 1623 |
|
|
2016
Q4 | $484K | Sell |
4,201
-1,588
| -27% | -$183K | 0.06% | 321 |
|
|
2016
Q3 | $684K | Buy |
5,789
+840
| +17% | +$102K | 0.07% | 260 |
|
|
2016
Q2 | $600K | Buy |
4,949
+1,376
| +39% | +$156K | 0.08% | 259 |
|
|
2016
Q1 | $387K | Sell |
3,573
-837
| -19% | -$86.7K | 0.05% | 345 |
|
|
2015
Q4 | $453K | Sell |
4,410
-1,185
| -21% | -$119K | 0.07% | 299 |
|
|
2015
Q3 | $522K | Buy |
5,595
+421
| +8% | +$40.7K | 0.08% | 269 |
|
|
2015
Q2 | $504K | Sell |
5,174
-1,793
| -26% | -$180K | 0.07% | 307 |
|
|
2015
Q1 | $701K | Buy |
6,967
+2,492
| +56% | +$253K | 0.1% | 248 |
|
|
2014
Q4 | $468K | Sell |
4,475
-688
| -13% | -$72.5K | 0.07% | 329 |
|
|
2014
Q3 | $550K | Sell |
5,163
-115
| -2% | -$11.9K | 0.08% | 327 |
|
|
2014
Q2 | $552K | Buy |
5,278
+1,559
| +42% | +$158K | 0.07% | 341 |
|
|
2014
Q1 | $365K | Sell |
3,719
-781
| -17% | -$72.4K | 0.05% | 524 |
|
|
2013
Q4 | $412K | Buy |
4,500
+570
| +15% | +$52.5K | 0.07% | 413 |
|
|
2013
Q3 | $341K | Sell |
3,930
-1,470
| -27% | -$132K | 0.06% | 391 |
|
|
2013
Q2 | $464K | Buy |
+5,400
| New | +$458K | 0.1% | 269 |
|
Other funds holding JNJ
VCM
VPM
Prelude Capital Management's JNJ Position: Q1 2026 in Review
Prelude Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 2,154 shares — an estimated $446K sold.
Prelude Capital Management first reported a position in JNJ in Q2 2013 and held it in 33 quarters. The position peaked at $3.58M in Q3 2024. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Prelude Capital Management reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
- Prelude Capital Management sold 2,154 Johnson & Johnson shares in Q1 2026, an estimated $446K.
- Prelude Capital Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 33 quarters.
- Prelude Capital Management's Johnson & Johnson position peaked at $3.58M in Q3 2024.
- 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.